RecruitingNot ApplicableNCT05371886
Pharmacokinetics-pharmacodynamics of Morphine With or Without Midazolam Administered by Continuous Infusion in Neonatal Intensive Care
Sponsor
Centre Hospitalier Intercommunal Creteil
Enrollment
180 participants
Start Date
Apr 1, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
This study aims to describe a dose-effect relationship of morphine alone and morphine and midazolam administered as continuous infusion in neonates hospitalized in Neonatal intensive care unit and undergoing mechanical ventilation, through PKPD modelling.
Eligibility
Min Age: 20 WeeksMax Age: 45 Weeks
Inclusion Criteria5
- Neonates \< 45 weeks of corrected gestational age
- Hospitalized in a Neonatal Intensive Care Unit
- Undergoing mechanical ventilation
- Patients that receive morphine alone or morphine and midazolam as continuous infusion
- Affiliated to a social security system
Exclusion Criteria6
- Current weight \< 600g
- Neonates under palliative care
- Therapeutic hypothermia for perinatal anoxia
- Neonates who underwent a surgical procedure during the past 72 hours
- Neonates receiving concomitantly a paralytic or another drug for sedation or analgesia other than morphine or midazolam (except for paracetamol/acetaminophen)
- Parents refusing that their child participate
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERDose-effect relationship of morphine +/- midazolam administration
Dose-effect relationship of morphine +/- midazolam administration as continuous infusion in neonates undergoing mechanical ventilation through PKPD modelling
Locations(5)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05371886
Related Trials
A Comparison of Remimazolam Besylate and Propofol Sedation in Patients Undergoing Colonoscopic Polypectomy
NCT074561111 location
Goal-Directed Sedation in Mechanically Ventilated Infants and Children
NCT048015891 location
multipaRameter mOnitoring systeM for sedAtion iNThe ICu
NCT066678692 locations
Validation of a Processed EEG Device for Monitoring Sedation in PICU
NCT059694831 location
Effect of Goal-directed Analgesia and Sedation Using EEG Derived QCON/qNOX in ICU Patients
NCT067693082 locations